- Advertisement -

International Biotechnology Trust : Pandemic provides launchpad for multi-year biotech boom – Marketscreener.com

The biotech sector has been propelled into the limelight over the past year, with the successful development of the Covid-19 vaccine offering the...

Moderna’s coronavirus vaccine candidate shows promise in phase I trial

The world is one small step closer to having a vaccine against the novel coronavirus as Moderna, a U.S. based biotechnology firm, announced promising...

Controlling KRAS: Allosteric Sites Mapped on Key Cancer Protein

Researchers at the Centre for Genomic Regulation and the Wellcome Sanger Institute have comprehensively identified the allosteric control sites found in the protein KRAS,...

First CRISPR-armed phage therapeutic can specifically target and remove E. coli...

SNIPR Biome ApS ("SNIPR"), the company pioneering CRISPR-based microbial gene therapy, announces today that Nature Biotechnology has published research findings from its preclinical work...

Red Biotechnology Market Increasing Demand with Leading Player, Comprehensive Analysis and...

Pfizer IncThe competitive landscape of the Red Biotechnology market is examined in detail in the report, with a focus on the latest developments, the...

Dr. Marie-Claude Morice to receive the 2021 Andreas Gruntzig Ethica Award

Dr. Morice’s contributions to the PCR mission are to be recognised at the EuroPCR 2021 Course Credit: PCR

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key tumor defense against...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...

more new items

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...